Related Experiment Video
Updated: Jul 3, 2026
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up
M Ozawa1, P I Terasaki, R Castro
1One Lambda, Inc., Los Angeles, CA, USA.
Insights
Post-transplant HLA antibodies significantly predict long-term graft loss in organ transplant recipients. Antibody-positive patients experienced twice the rate of graft failure compared to antibody-negative patients over three years.
Area of Science:
- Transplantation immunology
- Clinical transplantation research
- Immunogenetics
Background:
- Post-transplant antibodies are a known risk factor for organ transplant rejection.
- Understanding the precise impact of HLA antibodies on long-term graft survival is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the predictive value of post-transplant HLA antibodies for long-term graft loss.
- To assess the association between antibody characteristics (specificity, strength) and graft failure across different solid organ transplants.
Main Methods:
- Analysis of a large cohort (4,144 patients) from the 14th International Workshop Prospective Chronic Rejection study.
- Three-year follow-up data collection on graft survival in relation to pre-transplant and post-transplant HLA antibody status.
- Stratification of antibody analysis by donor-specificity and non-donor-specific antibody strength.
Main Results:
- A significant association was found between post-transplant HLA antibody positivity and graft loss at three years (10% vs. 5%, p<0.0001).
- This association was consistent across kidney, lung, heart, and liver transplants.
- Donor-specific antibodies and strong non-donor-specific antibodies demonstrated a stronger link to graft loss than moderate non-donor-specific antibodies.
Conclusions:
- Post-transplant HLA antibodies are a strong predictor of long-term graft loss across multiple solid organ types.
- Periodic monitoring of HLA antibodies, including specificity and strength, can identify high-risk allograft recipients.
- These findings support proactive monitoring strategies to mitigate graft failure.
Abstract:
The three-year follow-up of 4,144 patients of the 14th International Workshop Prospective Chronic Rejection study has reinforced the evidence that post-transplant HLA antibodies are predictive of long-term graft loss. Three years after a single testing for HLA antibodies, 10% of kidney recipients who were antibody-positive had lost their grafts, in contrast to only 5% of antibody-negative patients (p<0.0001). The adverse effect of post-transplant antibodies on graft survival was also observed in lung, heart, and liver transplants. Donor-specific antibodies and 'strong' non-DSA had stronger association with graft loss than 'moderate' non-DSA. Periodic antibody monitoring, combined with specificity and strength analysis, would help in the early identification of allograft recipients who are at high risk of graft failure.